Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $778M | $818M | $931M | $1.00B | $1.05B | $1.10B | $1.16B |
| Revenue growth | — | 5.1% | 13.9% | 7.8% | 4.5% | 4.9% | 5.7% |
| Gross profit | $395M | $444M | $519M | $557M | $577M | $602M | $646M |
| Gross margin | 50.8% | 54.2% | 55.7% | 55.5% | 55.0% | 54.7% | 55.5% |
| Operating income | $184M | $206M | $257M | $248M | $277M | $298M | — |
| Operating margin | 23.6% | 25.2% | 27.6% | 24.7% | 26.4% | 27.0% | — |
| Net income | -$20.9M | -$38.6M | $117M | -$234M | $51.4M | $44.4M | $77.9M |
| Net margin | -2.7% | -4.7% | 12.5% | -23.3% | 4.9% | 4.0% | 6.7% |
| EPS (diluted) | -$0.09 | -$0.16 | $0.41 | -$0.83 | $0.18 | $0.16 | $0.27 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $149M | $121M | $282M | $278M | -$148M | $224M | $287M |
| Capital expenditures | $57.3M | $53.5M | $102M | $182M | $215M | $179M | $138M |
| Free cash flow | $91.8M | $67.1M | $179M | $95.6M | -$363M | $45.1M | $149M |
| Share buybacks | $0.00 | $34.0M | $0.00 | $0.00 | — | — | — |
| Dividends paid | $691M | $0.00 | $0.00 | — | — | — | — |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $63.0M | $102M | $107M | $395M | $296M | $277M | $345M |
| Total assets | — | $2.76B | $2.79B | $3.12B | $3.13B | $3.07B | $3.26B |
| Total liabilities | — | $2.31B | $2.20B | $2.77B | $2.69B | $2.67B | $2.66B |
| Long-term debt | — | $1.82B | $1.74B | $1.75B | $2.22B | $2.21B | $2.13B |
| Shareholders' equity | -$641M | $452M | $586M | $350M | $444M | $405M | $606M |
| Retained earnings | — | -$589M | -$472M | -$706M | -$654M | -$610M | -$532M |
| Shares (wtd avg diluted) | 232M | 238M | 279M | 280M | 283M | 285M | 286M |
Every figure is extracted from Sotera Health Co’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.